Perform Another (Advanced) Search

1.  CenterWatch: Clinical Trials in Category (82) Huntington's Disease
...CenterWatch: Clinical Trials in Category (82) Huntington's Disease Huntington's Disease State • Massachusetts • Virginia Massachusetts Boston : Massachusetts General Hospital New! Creatine, Tolerability ...
View Page

2.  CenterWatch: New Medical Therapies in Disease Category (82), Huntington's Disease
...CenterWatch: New Medical Therapies in Disease Category (82), Huntington's Disease Huntington's Disease Patient Medical Areas • Neurology August 4, 2008 Medivation released positive results ...
View Page

3.  Study Posting (799) Trial #152239, Huntington's Disease, Charlestown, MA
...Study Posting (799) Trial #152239, Huntington's Disease, Charlestown, MA Trial Information Tissue Donation for Huntington's Disease Brain Donation: Huntington’s ...
View Page

4.  Study Posting (713) Trial #95527, Huntington's Disease, Charlottesville, VA
...Study Posting (713) Trial #95527, Huntington's Disease, Charlottesville, VA Trial Information Individuals who are affected by Huntington's Disease for a ...
View Page

5.  Study Posting (799) Trial #159981, Huntington's Disease, Boston, MA
...Study Posting (799) Trial #159981, Huntington's Disease, Boston, MA Trial Information Premanifest Huntington's Disease: Creatine Safety and Tolerability (Pre-CREST ...
View Page

6.  Study Posting (799) Trial #159982, Huntington's Disease, Boston, MA
...Study Posting (799) Trial #159982, Huntington's Disease, Boston, MA Trial Information Creatine, Tolerability, and Efficacy in Huntington's Disease (CREST-E ...
View Page

7.  Study Posting (799) Trial #153452, Huntington's Disease, Boston, MA
...Study Posting (799) Trial #153452, Huntington's Disease, Boston, MA Trial Information Creatine, Tolerability, and Efficacy in Huntington's Disease (CREST-E ...
View Page

8.  Newly Approved Drug Therapies (992) Xenazine (tetrabenazine), Prestwick Pharma,
...Xenazine (tetrabenazine) Company: Prestwick Pharma Approval Status: Approved August 2008 Treatment Area: chorea due to Huntington's disease General Information Xenazine (tetrabenazine) is a monoamine depletor for oral administration. The precise mechanism ...
View Page

9.  Study Posting (573) Trial #158725, Alzheimer's Disease, Raleigh, NC
...past 4 months 50 years of age or older • Not previously diagnosed with vascular dementia, Huntington’s Disease, Parkinson’s Disease, or seizures • Not living in a nursing home • Able to have ...
View Page

10.  CenterWatch New Medical Therapies™ in Neurology
...Chronic Pain Dementia Diabetic Neuropathy Dizzy/Fainting Spells Dyskinesias Epilepsy Fabry Disease Fibromyalgia Herpetic Neuralgia Huntington's Disease Insomnia Leber's Hereditary Optic Neuropathy (LHON) Memory Loss Memory Problems Meningitis Mental Disability ...
View Page

11.  CenterWatch: New Medical Therapies in Disease Category (441), Seizure Disorders (Pediatric)
...Amarin reported negative results from two phase III trials of Miraxion for the treatment of Huntington's disease. These randomized, double-blind, placebo-controlled trials enrolled 600 subjects who received Miraxion 2g ...
View Page

12.  CenterWatch: Musculoskeletal Approved Drug Therapies
...Arthritis, Approved April 2008 Xenazine (tetrabenazine) ; Prestwick Pharma; For the treatment of chorea due to Huntington's disease, Approved August 2008 Drugs Approved in 2007 Amrix (cyclobenzaprine hydrochloride extended release) ; Cephalon; For ...
View Page

13.  CenterWatch: Clincial Trial Listings in Neurology
...New! ) Epilepsy   (45, 4 New! ) Epilepsy (Pediatric)   (1) Fibromyalgia   (96) Headaches   (1) Herpetic Neuralgia   (2) Huntington's Disease   (3, 2 New! ) Insomnia   (57, 3 New! ) Learning Disorders   (1) Memory Loss   (38, 4 ...
View Page

14.  CenterWatch Clinical Research Profile (749) Trial #328, Struthers Parkinson's Center, Minneapolis, MN
...of Virginia • Board-certified in neurology and medical genetics • Specialties: Parkinson's disease, Ataxia and Huntington's disease • Advanced training in neurology, University of Minnesota • Advanced training in medical genetics, University of ...
View Page

15.  CenterWatch: New Medical Therapies in Disease Category (608), Pseudobulbar Affect
...of data from their phase III study of Miraxion (LAX-101) , for the treatment of Huntington’s disease. Original results from the study, announced October 2002, indicated that Miraxion was not significantly ...
View Page

16.  Study Posting (2829) Trial #155110, Alzheimer's Disease, San Antonio, TX
...past 4 months. • 50 years of age or older • Not previously diagnosed with vasculare dementia, Huntington's Disease, Parkinson's Disease or seizures • Not living in a nursing home • Able to have ...
View Page

17.  Study Posting (5217) Trial #158834, Alzheimer's Disease, National City, CA
...past 4 months • 50 years of age or older • Not previously diagnosed with vascular dementia, Huntington’s Disease, Parkinson’s Disease, or seizures • Not living in a nursing home • Able to have ...
View Page

18.  Study Posting (5217) Trial #158833, Alzheimer's Disease, National City, CA
...past 4 months • 50 years of age or older • Not previously diagnosed with vascular dementia, Huntington’s Disease, Parkinson’s Disease, or seizures • Not living in a nursing home • Able to have ...
View Page

19.  CenterWatch: List of Newly Approved Drug Thearapies
...Arthritis, Approved April 2008 Xenazine (tetrabenazine) ; Prestwick Pharma; For the treatment of chorea due to Huntington's disease, Approved August 2008 Nephrology/Urology Degarelix (degarelix for injection) ; Ferring Pharmaceuticals; For the treatment ...
View Page

20.  CenterWatch Trial Listings By Disease Category
...Hormone Replacement Therapy: Menopause   (1) Hot Flash   (24, 1 New! ) Human Papilloma Virus (HPV)   (47) Huntington's Disease   (3, 2 New! ) Hyperparathyroidism   (1) Hypertension (High Blood Pressure - Pediatric)   (5) Hypertension (High Blood ...
View Page